Darwin Global Management, Ltd.

Position in ROIV — Roivant Sciences Ltd.

CIK 1839209 ST. HELIER, Y9

Position in ROIV

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$238,786,947

+$50,501,737 QoQ

Shares Held

6,747,300

-0.7% QoQ

Ownership

0.934%

of shares outstanding

% of Portfolio

6.17%

of 13F equity value

Holder Rank

#18

of 494 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Darwin Global Management, Ltd. holds $3,871,688,327 across 5 Biotechnology names. ROIV ranks #5 (6.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	10,629,822	$1,990,753,064
2	INSM	INSMED Inc	6,431,163	$685,690,599
3	ABVX	Abivax S.A.	3,621,583	$482,612,150
4	BLTE	Belite Bio, Inc	3,077,219	$473,845,567
5	ROIV	Roivant Sciences Ltd. This page	6,747,300	$238,786,947

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$238,786,947	6,747,300	-0.7%	Shares	Sole	2026-08-14
2026-03-31	$188,285,210	6,797,300	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.